Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
2013 Dec;23(12):1167-74.
Caroline Geisler presented preclinical data highlighting the role of glial cells in mediating GLP-1 action in the brain
She tracks progress with monthly photos
A diferencia de los medicamentos agonistas de GLP-1 aprobados por la FDA, los potenciadores naturales trabajan estimulando la secrecin fisiolgica de GLP-1 mediante alimentos especficos ricos en fibra, protenas y compuestos bioactivos
This pigmentation effect: Can confound behavioral assays that rely on visual observation of coat color (e.g., agouti gene expression studies) Serves as a visual pharmacodynamic marker confirming MC1R engagement and compound activity Is relevant to research on melanoma biology, melanocyte function, and photoprotection May complicate blinding in non-pharmacological behavioral studies PT-141's minimal MC1R activity eliminates this pigmentation confound, making it the preferred compound for CNS-focused research where skin color changes would be undesirable
Next, the effects of GLP-1-induced AMPK activation on PARP-1 activity and ABCA1 expression were examined
